Archive for October, 2008

Five things you can do to prevent ANTHRAX, naturally

Monday, October 27th, 2008

Written for An Ounce of Prevention, the newsletter of the Apple-A-Day
Service Group, an international organization of naturopathic
practitioners based out of Austin, Texas.At Apple-A-Day Clinic we are receiving many calls from people
concerned about Anthrax and other terrorist-initiated diseases.
>From the news, we learn that people are so frightened that they are
taking antibiotics that cause dangerous side effects even though
they have no known reason to do so. A…

Journal of Family Practice - Bullous eruption on the posterior thigh

Saturday, October 25th, 2008

A healthy 11-year-old girl visited her family physician with a lesion on her right posterior thigh. The lesion was a 1-cm plaque that was tender, firm, erythematous, and indurated, with a central pustule. It had been present for 3 days; it was noticed by the patient after returning from…

Dog Otitis Externa - Care of Ear Infection & Prevention

Friday, October 24th, 2008

Otitis externa is an inflammation of the outer ear and ear canal. Inflammation of the skin of the ear canal is the essence of this disorder. The inflammation can be secondary to dermatitis (eczema) only, with no microbial infection, or it can be caused by active bacteri…

Pediatric Nursing - Community-associated MRSA in the pediatric primary care setting

Saturday, October 18th, 2008

Case Study
Michael, age 4 years, was seen in November for two swollen, red-appearing lesions on his abdomen. The initial diagnosis was cellulites secondary to insect bites. He was prescribed Cephalexin (Keflex[R]) 250 mg TID for 10 days with warm compresses to th…

American Family Physician - Management of Staphylococcus aureus infections

Friday, October 17th, 2008

Because of high incidence, morbidity, and antimicrobial resistance, Staphylococcus aureus infections are a growing concern for family physicians. Strains of S. aureus that are resistant to vancomycin are now recognized. Increasing incidence of unrecognized community-acquired methicillin-resistant S. aureus infections pose a high risk for …

Chronic Sinusitis Suffers Benefit From Serrapeptase

Wednesday, October 15th, 2008

Serrapeptase is a proteolytic enzyme isolated from the micro-organism Serratia E15. Serrapeptase is used as an alternative to Non Steroidal Anti-Inflammatory Drugs (NSAIDS) which are commonly used to treat arthritis and inflammation. This enzyme can help reduce inflammation, pain and more.
Sinusitis can be chronic or reoccurring each month causing great pain and suffering to those who have it. Luck…

Journal of Drugs in Dermatology - Clinical trial review

Monday, October 13th, 2008

Clinical Trial Review is designed to provide physicians with as much information as possible about drugs undergoing Phase 1,.2, and 3 clinical testing. It is our goal to inform the reader of the up-to-date status of these drug trials before this information is available through standard channels: To participate in or learn more about these and additional trials, visit www.clinicaltrials.gov….

Journal of Family Practice - Diabetic foot ulcer and poor compliance: how would you treat?

Saturday, October 11th, 2008

A 45-year-old Caucasian man, M.N., visits his family physician for a follow-up examination of the ulcer on his right foot. Today the patient reports that his foot feels more swollen. He has no pain, fever, or chills. Nine months ago M.N. began to exhibit a ca…

M2 Presswire - Bellwether Report.com is Doing Due-Diligence on Advancis Pharmaceutical Corp.

Tuesday, October 7th, 2008

M2 PRESSWIRE-5 October 2006-bellwetherreport.com: Bellwether Report.com is Doing Due-Diligence on Advancis Pharmaceutical Corp.(C)1994-2006 M2 COMMUNICATIONS LTD RDATE:05102006 Bellwether Report Takes Notice of Advancis Pharmaceutical Corp. (Nasdaq:AVNC) The company is developing new formulations of existing antibiotics that are no longer patent protected, using its PULSYS once-a-day pu…

M2 Presswire - Shareholder Alert for Advancis Pharmaceutical Corporation.

Saturday, October 4th, 2008

M2 PRESSWIRE-10 April 2007-Biotech News: Shareholder Alert for Advancis Pharmaceutical Corporation(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:10042007 Advancis Pharmaceutical Corporation has its fingers on the pulse in the fight against bacteria. The company is developing new formulations of existing antibiotics…